Pentanal

Pentanal

SCHEMBL4430016

CCCCC=O.[SnH4]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pentanal SCHEMBL28721 0.97
Pentanal SCHEMBL622584 0.97 TSHR (1.00)
Pentanal SCHEMBL5172697 0.93
Pentanal SCHEMBL1628430 0.93
Pentanal SCHEMBL11299036 0.93
Pentanal SCHEMBL11434933 0.93
Pentanal SCHEMBL7624050 0.93
Pentanal SCHEMBL3801508 0.93
Pentanal SCHEMBL24385 0.93
Pentanal SCHEMBL4581160 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125806-A1 COMPOUNDS HAVING BOTH ANGIOTENSIN II RECEPTOR ANTAGONISM AND PPARY ACTIVATING ACTIVITIES Pfizer Products Inc. (US) 2009-12-02 EP disclosed
WO-2008084303-A1 COMPOUNDS HAVING BOTH ANGIOTENSIN II RECEPTOR ANTAGONISM AND PPARY ACTIVATING ACTIVITIES PFIZER PRODUCTS INC. (US) 2008-07-17 WO disclosed